Literature DB >> 12645942

Normal B-1 cell development but defective BCR signaling in Lck-/- mice.

Cristina Ulivieri1, Silvia Valensin, M Bernardetta Majolini, R James Matthews, Cosima T Baldari.   

Abstract

Mature B cells are grouped into two major subsets, B-1 and B-2, believed to derive from separate lineages. We have recently shown that B-1 cells, which are characterized by CD5 surface expression, specifically exhibit significant levels of the tyrosine kinase Lck in man. Here we show that also in mice Lck expression is restricted to B-1 cells and address the potential role of Lck in B-1 cell development and activation. Using as a model an Lck-/- mouse, we show that, while dispensable for B-1 cell development, Lck is required for full and sustained activation of the tyrosine phosphorylation and MAP kinase cascades triggered by the BCR in CD5+, B-1 cells. The data suggest a potential role for Lck in the achievement of the higher activation threshold required for productive BCR signaling in B-1 as compared to B-2 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645942     DOI: 10.1002/immu.200310019

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 2.  Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?

Authors:  John C Allen; Fatima Talab; Joseph R Slupsky
Journal:  Int J Hematol Oncol       Date:  2016-05-26

3.  T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.

Authors:  Colin J Daniel; Carl Pelz; Xiaoyan Wang; Michael W Munks; Aaron Ko; Dhaarini Murugan; Sarah A Byers; Eleonora Juarez; Karyn L Taylor; Guang Fan; Lisa M Coussens; Jason M Link; Rosalie C Sears
Journal:  Mol Cancer Res       Date:  2022-07-06       Impact factor: 6.333

4.  Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice.

Authors:  Takeo Ohsugi
Journal:  J Vet Med Sci       Date:  2017-03-12       Impact factor: 1.267

5.  Dermatan Sulfate Is a Potential Regulator of IgH via Interactions With Pre-BCR, GTF2I, and BiP ER Complex in Pre-B Lymphoblasts.

Authors:  Jongmin Lee; Jung-Hyun Rho; Michael H Roehrl; Julia Y Wang
Journal:  Front Immunol       Date:  2021-05-25       Impact factor: 7.561

6.  New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insights.

Authors:  Ahmed Elkamhawy; Eslam M H Ali; Kyeong Lee
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

7.  Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia.

Authors:  Melanie Märklin; Alexander R Fuchs; Claudia Tandler; Jonas S Heitmann; Helmut R Salih; Joseph Kauer; Leticia Quintanilla-Martinez; Stefan Wirths; Hans-Georg Kopp; Martin R Müller
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.